Stable coronary artery disease - Diagnostics and therapy;Stabile koronare herzerkrankung - Diagnostik und therapie

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 11, 2006, Pages 556-562

  Laufs, Ulrich ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CAROTENE; CALCIUM ANTAGONIST; CYANOCOBALAMIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; PROSTAGLANDIN SYNTHASE; PYRIDOXINE; THROMBOXANE A2;

ALCOHOL CONSUMPTION; ANAMNESIS; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ELECTROCARDIOGRAM; HORMONAL THERAPY; HUMAN; HYPERLIPIDEMIA; OBESITY; PROGNOSIS; REVIEW; SOCIAL PSYCHOLOGY; STABLE ANGINA PECTORIS; VITAMIN SUPPLEMENTATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTILIPEMIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; HUMANS; LIPIDS; PHYSICAL EXAMINATION; PROGNOSIS; RADIOGRAPHY, THORACIC; RISK FACTORS;

EID: 33645687832     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-933696     Document Type: Review

References (35)

1. American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 1998; 30: 975-991
2. Arzneikommission der Deutschen Ärzteschaft (www.akdae.de). Empfehlungen zur Prophylaxe und Therapie der stabilen koronare Herzkrankheit. Arzneiverordnung in der Praxis, 2004: 1
3. Arzneimittelkommission der deutschen Ärzteschaft (Hrg.). Koronare Herzkrankheit. Arzneiverordnungen Deutscher Ärzte-Verlag Köln, 2006; 21. Aufl
4. Arzneimitteikommission der Deutschen Ärzteschaft (www.akdae.de). Therapieempfehlung Arterielle Hypertonie. Dr Ärzte-Verl Köln, 2002: 49-65
5. Arzneimittelkommission der Deutschen Ärzteschaft (www.akdae.de). Therapieempfehlung Diabetes mellitus. Dt Ärzte-Verl Köln, 2002: 49-65
6. Arzneimittelkommission der Deutschen Ärzteschaft (www.akdae.de). Therapieempfehlung Fettstoffwechselstörungen. Dt Ärzte-Verl Köln, 2002: 169-189
7. Arzneimittelkommission der Deutschen Ärzteschaft (www.akdae.de). Therapieempfehlung Tabakabhängigkeit. Dt Ärzte-Verl Köln, 2002: 249-277
8. Arzneimittelkommission der Deutschen Ärzteschaft (www.akdae.de). Therapieempfehlung zur Therapie mit Östrogenen/Östrogen-Gestagen- Kombinationen in Klimakterium und Postmenopause. Dt Ärzte-Verl Köln, 2003
9. Ärztliches Zentrum für Qualität in der Medizin. Nationale Versorgungs-Leitlinie "Chronische KHK", vorläufige Fassung. http://www Versorgungsleitlinien de, 2005
10. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572
11. Deutsche Hochdruckliga. Empfehlungen zur Hochdruckbehandlung. 18. Auflage (Hrsg). www hochdruckliga info, 2003
12. Dietz R, Rauch B. Leitlinie zur Diagnose und Behandlung der chronischen koronaren Herzerkrankung der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung (DGK). Z Kardiol 2003; 92: 501-521
13. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519
14. Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ 2002; 325: 188
15. Fletcher GF, Balady G, Blair SN et al. Statements on exercise: benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1996; 94: 857-862
16. Fletcher GF, Balady GJ, Amsterdam EA et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 1694-1740
17. Gibbons RJ, Abrams J, Chatterjee K et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2003; 41: 159-168
18. Gibbons RJ, Balady GJ, Timothy BJ. ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002; 106: 1883-1892
19. Gielen S, Schuler G, Hambrecht R. Exercise training in coronary artery disease and coronary vasomotion. Circulation 2001; 103: E1-E6
20. Gohlke H, Kübler W, Mathes P, Meinertz T, Schuler G, Gysan D, Sauer G. Positionspapier zur Primärprävention kardiovaskulärer Erkrankungen. Z Kardiol 2003; 92: 522-524
21. Goldberg IJ, Mosca L, Piano MR, Fisher EA. Wine and Your Heart: A Science Advisory for Healthcare Professionals From the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation 2001; 103: 472-475
22. Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-239
23. Hamm CW. Guidelines: Acute coronary syndrome with ST-elevation. Z Kardiol 2004; 93: 324-341
24. Hamm CW. Guidelines: acute coronary syndrome without persistent ST segment elevations. Z Kardiol 2004; 93: 72-90
25. Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Circulation 2005; H2: e154-e235
26. Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Database Syst Rev 2004: CD000165
27. Laufs U, Böhm M. Die Grippeimpfung - eine kosteneffiziente Prophylaxe der koronaren Herzkrankheit. Deutsches Ärzteblatt 2005; 102: 2289-2292
28. Mosca L, Appel LJ, Benjamin EJ et al. Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol 2004; 24: e29-e50
29. National Cholesterol Education Program Expert Panel. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Heart, Lung, and Blood Institute, National Institutes of Health, Publication No 02-5215, 2002: 3143-3421
30. Nichol KL, Nordin J, Mullooly J et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322-1332
31. Robert Koch-Institut. Empfehlungen der ständigen Impfkommission. Epidemiologisches Bulletin 2004; 30: 235-250
32. Song F, Raftery J, Aveyard P et al. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Med Decis Making 2002; 22: S26-S37
33. Woolacott NF, Jones L, Forbes CA et al. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess 2002; 6: 1-245
34. Yusuf S, Hawken S, Ounpuu S et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649
35. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952